心脏性猝死的预防及我国埋藏式心律转复除颤器应用状况The prevention of sudden cardiac death and clinical application of implantable cardioverter-defibrillator in Mainland of China
张澍,华伟,陈柯萍,王方正,陈新
摘要(Abstract)：
目的 通过对全国部分医院的回顾性调查研究 ,了解我国埋藏式心律转复除颤器 (ICD)使用状况。方法 回顾性分析了 1996年 1月 18日到 2 0 0 3年 1月 31日 ,来自 82家医院的 173例ICD患者的临床情况 ,了解其基础病因、心律失常类型、ICD对心律失常的治疗情况以及ICD的并发症。结果 173例植入ICD患者 ,其中 115例 (6 6 5 % )有各种器质性心脏病 ,以冠心病为最常见。植入患者中室性心动过速 (VT) 10 6例 (6 1 3% ) ,心室颤动 (VF) 34例 (19 6 % ) ,VT合并VF 33例 (19 1% )。在平均随访 2 7 8个月 (1～ 86个月 )中 ,82例 (47 4 % )发生VT和 或VF ,并接受ICD成功治疗 ;73 0 4 %的VT通过抗心动过速起搏 (ATP)终止 ;VF除颤成功率为 10 0 % ;误放电率为 2 0 %。术后并发症发生率为 2 3% ,随访期间共有 11例患者死亡 ,占 6 4 %。结论 本研究的有限数据表明ICD治疗对我国患者带来的好处 ,但其应用尚处于起步阶段。
关键词(KeyWords)： 心脏性猝死;心律失常;埋藏式心律转复除颤器
基金项目(Foundation):
作者(Author): 张澍,华伟,陈柯萍,王方正,陈新
参考文献(References)：
- 1TheAVIDinvestigators.AComparisonofantiarrhythmicdrugtherapywithimplantabledefibrillatorsinpatientsresuscitatedfromnear fatalsustainedventriculararrhythmias.NEnglJMed,1997,337:15761583.
- 2KuckKH ,CappatoR ,SiebelsJ,etal.fortheCASHinvestigators.Randomizedcomparisonofantiarrhythmicdrugtherapywithimplantabledefibrillatorsinpatientsresuscitatedfromcardiacarrest.Circulation,2000,102:748754.
- 3ConnollySJ,GentM ,RobertsRS ,etal.CanadianImplantableDefibrillatorStudy(CIDS):Arandomizedtrialoftheimplantablecardioverteragainstamiodarone.Circulation,2000,101:12971302.
- 4MossAJ,HallJ,CannomDS ,etal.Improvedsurvivalwithanimplanteddefibrillatorinpatientswithcoronarydiseaseathighriskforventriculararrhythmia.NEnglJMed,1996,335:19331940.
- 5MossAJ,CannomDS ,DaubertJP ,etal.fortheMADITIIinvestigators,MulticenterautomaticdefibrillatorimplantationtrialⅡ(MADITⅡ):designandclinicalprotocol.AnnNoninvasiveElectrocardiol,1999,4:8391.
- 6BuxtonAE ,LeeKL ,FisherJD ,etal.Arandomizedstudyofthepreventionofsuddendeathinpatientswithcoronaryarterydisease.NEnglJMed,1999,341:18821890.
- 7FogorosRN ,ElsonJJ,BonnetCA ,etal.Efficacyoftheautomaticimplantablecardioverter defibrillatorinprolongingsurvivalinpatientswithsevereunderlyingcardiacdisease,JAmCollCardiol,1990,16:381386.
- 8PowellAC ,FuchsT ,FinkelsteinDM ,etal.Influenceofimplantablecardioverter defibrillatorsonthelong termprognosisofsurvivorsofout of hospitalcardiacarrest.Circulation,1993,88:10831092.
- 9WeverEF ,HauerRN ,vanCapelleFL ,etal.Randomizedstudyofimplantabledefibrillatorasfirst choicetherapyversusconventionalstrategyinpostinfarctsuddendeathsurvivors.Circulation,1995,91:21952203.
- 10MossAJ.Implantablecardioverterdefibrillatortherapy:thesickestpatientsbenefitthemost.Circulation,2000,101:16381640.
- 11ZipesDP ,RobertsD ,forthePacemakerCardioverterDefibrillatorInvestigators.Resultsoftheinternationalstudyoftheimplantablepacemakercardioverter defibrillator:acomparisonofepicardialandendocardialleadsystems.Circulation,1995,92:5965.
- 12SaksenaS ,forthePCDInvestigators.Clinicaloutcomeofpatientswithmalignantventriculartachyarrhythmiasandamultiprogrammableimplantablecardioverter defibrillatorimplantedwirhorwithoutthoracotomy:aninternationalMulticenterstudy.JAmCollCardiol,1994,23:15211530.
- 13PinskiSL ,FahyGJ.Theproarrhythmicpotentialofimplantablecardioverter defibrillators.Circulation,1995,92:16511664.
- 14ACC AHA NASPE 2002GuidelineUpdateforImplantationofCardiacPacemakersandAntiarrhythmiaDevices.Circulation,2002,106:21452161.